Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
Mireia Pesarrodona(Universitat Autònoma de Barcelona), Esther Vázquez, Simó Schwartz(CIBBIM-Nanomedicine), Joaquin Seras‐Franzoso(Vall d'Hebron Institut de Recerca), Zamira V. Díaz‐Riascos(Vall d'Hebron Institut de Recerca), Ursula Rinas(Leibniz University Hannover), Antonio Villaverde(Universitat Autònoma de Barcelona), Sandra Mancilla(Universitat Autònoma de Barcelona), Ibane Abasolo(Unknown), Laura Soucek(Institució Catalana de Recerca i Estudis Avançats), Ricardo Baltà‐Foix(Universitat Autònoma de Barcelona), Toni Jauset(Vall d'Hebron Institut de Recerca), Laura Sánchez‐García(Universidade de Santiago de Compostela), Marie-Ève Beaulieu(Vall d'Hebron Institut de Recerca), Yolanda Fernández(CIBBIM-Nanomedicine), Alejandro Sánchez‐Chardi(Universitat Autònoma de Barcelona)
Cited by 50
Related Papers
Drugging the 'undruggable' cancer targets
|Nature reviews. Cancer|2017|912
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
|Blood|2011|382
Strategies to Inhibit Myc and Their Clinical Applicability
|Frontiers in Cell and Developmental Biology|2017|296
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis
|Nature Communications|2014|195
Bacterial Inclusion Bodies: Discovering Their Better Half
|Trends in Biochemical Sciences|2017|181